Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension

Hameed, Abdul G, Arnold, Nadine D, Chamberlain, Janet, Pickworth, Josephine A, Paiva, Claudia, Dawson, Sarah, Cross, Simon, Long, Lu, Zhao, Lan, Morrell, Nicholas W, Crossman, David C, Newman, Christopher M H, Kiely, David G, Francis, Sheila E and Lawrie, Allan (2012) Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension. Journal of Experimental Medicine, 209 (11). pp. 1919-35. ISSN 0022-1007

Full text not available from this repository.

Abstract

Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by the progressive narrowing and occlusion of small pulmonary arteries. Current therapies fail to fully reverse this vascular remodeling. Identifying key pathways in disease pathogenesis is therefore required for the development of new-targeted therapeutics. We have previously reported tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) immunoreactivity within pulmonary vascular lesions from patients with idiopathic PAH and animal models. Because TRAIL can induce both endothelial cell apoptosis and smooth muscle cell proliferation in the systemic circulation, we hypothesized that TRAIL is an important mediator in the pathogenesis of PAH. We demonstrate for the first time that TRAIL is a potent stimulus for pulmonary vascular remodeling in human cells and rodent models. Furthermore, antibody blockade or genetic deletion of TRAIL prevents the development of PAH in three independent rodent models. Finally, anti-TRAIL antibody treatment of rodents with established PAH reverses pulmonary vascular remodeling by reducing proliferation and inducing apoptosis, improves hemodynamic indices, and significantly increases survival. These preclinical investigations are the first to demonstrate the importance of TRAIL in PAH pathogenesis and highlight its potential as a novel therapeutic target to direct future translational therapies.

Item Type:	Article
Uncontrolled Keywords:	adult,animals,anoxia,antibodies,apolipoproteins e,apoptosis,blotting, western,cell proliferation,cells, cultured,female,gene expression,humans,hypertension, pulmonary,male,mice,mice, inbred c57bl,mice, knockout,middle aged,muscle, smooth, vascular,myocytes, smooth muscle,pulmonary artery,rats, sprague-dawley,reverse transcriptase polymerase chain reaction,tnf-related apoptosis-inducing ligand,young adult,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit
Depositing User:	Pure Connector
Date Deposited:	20 Jan 2014 16:02
Last Modified:	24 Oct 2022 05:33
URI:	https://ueaeprints.uea.ac.uk/id/eprint/46178
DOI:	10.1084/jem.20112716

Actions (login required)

View Item